Business Description
Bioscience Animal Health PCL
ISIN : THA776010003
Compare
Compare
Traded in other countries / regions
BIS.Thailand IPO Date
2022-05-05Description
Bioscience Animal Health PCL along with its subsidiaries is engaged in the manufacturing, import and distribution of pharmaceutical supplies, medical devices, equipment and products for livestock and companion animals (pets). Geographically, the company generates revenue from Thailand, and also has presence in other countries.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 46.38 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.09 | |||||
Interest Coverage | 78.43 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.73 | |||||
Beneish M-Score | -3.38 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -2.5 | |||||
3-Year EBITDA Growth Rate | -10.8 | |||||
3-Year EPS without NRI Growth Rate | -14.5 | |||||
3-Year Book Growth Rate | 1 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 60.63 | |||||
9-Day RSI | 57.65 | |||||
14-Day RSI | 55.52 | |||||
3-1 Month Momentum % | 0.5 | |||||
6-1 Month Momentum % | 3.63 | |||||
12-1 Month Momentum % | -18.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.67 | |||||
Quick Ratio | 2.02 | |||||
Cash Ratio | 0.8 | |||||
Days Inventory | 51.32 | |||||
Days Sales Outstanding | 64.94 | |||||
Days Payable | 71.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 5.83 | |||||
Dividend Payout Ratio | 1.42 | |||||
3-Year Dividend Growth Rate | 41.5 | |||||
Forward Dividend Yield % | 3.88 | |||||
5-Year Yield-on-Cost % | 5.83 | |||||
Shareholder Yield % | 8.9 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 14.69 | |||||
Operating Margin % | 2.51 | |||||
Net Margin % | 1.7 | |||||
EBITDA Margin % | 3.4 | |||||
FCF Margin % | 10.05 | |||||
OCF Margin % | 10.25 | |||||
ROE % | 4.66 | |||||
ROA % | 3.01 | |||||
ROIC % | 7.5 | |||||
3-Year ROIIC % | 10.97 | |||||
ROC (Joel Greenblatt) % | 13.38 | |||||
ROCE % | 6.62 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 17.17 | |||||
PE Ratio without NRI | 17.17 | |||||
Price-to-Owner-Earnings | 3.56 | |||||
PS Ratio | 0.29 | |||||
PB Ratio | 0.81 | |||||
Price-to-Tangible-Book | 0.81 | |||||
Price-to-Free-Cash-Flow | 2.93 | |||||
Price-to-Operating-Cash-Flow | 2.87 | |||||
EV-to-EBIT | 6.71 | |||||
EV-to-EBITDA | 4.95 | |||||
EV-to-Revenue | 0.17 | |||||
EV-to-FCF | 1.67 | |||||
Price-to-GF-Value | 0.72 | |||||
Price-to-Graham-Number | 0.79 | |||||
| Price-to-Net-Current-Asset-Value | 1.09 | |||||
Earnings Yield (Greenblatt) % | 14.9 | |||||
FCF Yield % | 34.2 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bioscience Animal Health PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 2,200.595 | ||
| EPS (TTM) (฿) | 0.12 | ||
| Beta | 0.7551 | ||
| 3-Year Sharpe Ratio | -1.08 | ||
| 3-Year Sortino Ratio | -1.22 | ||
| Volatility % | 21.57 | ||
| 14-Day RSI | 55.52 | ||
| 14-Day ATR (฿) | 0.048427 | ||
| 20-Day SMA (฿) | 2.024 | ||
| 12-1 Month Momentum % | -18.7 | ||
| 52-Week Range (฿) | 1.7 - 3.12 | ||
| Shares Outstanding (Mil) | 314 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bioscience Animal Health PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bioscience Animal Health PCL Stock Events
| Event | Date | Price (฿) | ||
|---|---|---|---|---|
| THB 0.040000 Cash Dividend | 2026-04-29 | 2.10 (+1.94%) | ||
| THB 0.080000 Cash Dividend | 2025-08-20 | 2.58 (-0.77%) | ||
| THB 0.090000 Cash Dividend | 2025-04-30 | 2.66 (-2.92%) | ||
| THB 0.050000 Cash Dividend | 2024-08-27 | 3.30 (-0.60%) |
Show
Entries
Bioscience Animal Health PCL Frequently Asked Questions
What is Bioscience Animal Health PCL(BKK:BIS)'s stock price today?
The current price of BKK:BIS is ฿2.06. The 52 week high of BKK:BIS is ฿3.12 and 52 week low is ฿1.70.
When is next earnings date of Bioscience Animal Health PCL(BKK:BIS)?
The next earnings date of Bioscience Animal Health PCL(BKK:BIS) is .
Does Bioscience Animal Health PCL(BKK:BIS) pay dividends? If so, how much?
The Dividend Yield %  of Bioscience Animal Health PCL(BKK:BIS) is 5.83% (As of Today), Highest Dividend Payout Ratio of Bioscience Animal Health PCL(BKK:BIS) was 1.42. The lowest was 0.31. And the median was 0.61. The  Forward Dividend Yield % of Bioscience Animal Health PCL(BKK:BIS) is 3.88%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Bioscience Animal Health PCL
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers